These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14715700)

  • 21. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
    Ottino P; Taheri F; Bazan HE
    Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS; Nagle RB; Bowden GT
    Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
    Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M; Miyamori H; Yamashita J; Sato H
    Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
    Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
    Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
    Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C; Lamy S; Blanchette M; Boivin D; Gingras D; Béliveau R
    Free Radic Biol Med; 2006 Feb; 40(4):581-90. PubMed ID: 16458188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.
    Kazes I; Elalamy I; Sraer JD; Hatmi M; Nguyen G
    Blood; 2000 Nov; 96(9):3064-9. PubMed ID: 11049985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
    Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
    J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
    Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil activator of matrix metalloproteinase-2 (NAM).
    Rollo EE; Hymowitz M; Schmidt CE; Montana S; Foda H; Zucker S
    Clin Exp Metastasis; 2006; 23(5-6):259-68. PubMed ID: 17086359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts.
    Guo C; Piacentini L
    J Biol Chem; 2003 Nov; 278(47):46699-708. PubMed ID: 12970340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase.
    Kazes I; Delarue F; Hagège J; Bouzhir-Sima L; Rondeau E; Sraer JD; Nguyen G
    Kidney Int; 1998 Dec; 54(6):1976-84. PubMed ID: 9853262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.